Dry Powder Inhaler Devices Market: By Type (Capsule Based, Blister Based, Reservoir/Cartridge Based); By Therapeutics (Upper Respiratory, Asthma, COPD, Diabetes, Hereditary Diseases, Cystic Fibrosis and others) & By Region-Forecast 2019-2024
|粉末吸入器の世界市場予測：種類、治療対象、地域別の予測 Dry Powder Inhaler Devices Market: By Type (Capsule Based, Blister Based, Reservoir/Cartridge Based); By Therapeutics (Upper Respiratory, Asthma, COPD, Diabetes, Hereditary Diseases, Cystic Fibrosis and others) & By Region-Forecast 2019-2024|
|出版日: 2018年12月09日||ページ情報: 英文||
Dry-powder inhaler (DPI) is an alternative device to the aerosol-based inhalers commonly called metered-dose inhaler (or MDI) and help in delivering medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD, although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus. Globally, increasing number of people with respiratory diseases and diabetes mellitus are expected to remain the growth drivers for dry powder inhaler devices during the period of study.
Geographically, North America dominated the dry powder inhaler devices market driven by a world class healthcare infrastructure with a technologically advanced practice, higher spending, a high number of people with respiratory problems, strict guidelines and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for dry powder inhaler devices market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.
This report identifies the dry powder inhaler devices market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the dry powder inhaler devices market.
Dry powder inhaler devices market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Capsule Based Dry Powder Inhaler Device, Blister Based Powder Inhaler Device, Reservoir/Cartridge Based Powder Inhaler Device and Others
Dry powder inhaler devices market research report is classified on the basis of therapeutics. Some of the major therapeutics covered in this report are as follows: Upper Respiratory, Asthma, COPD, Diabetes, Hereditary Diseases, Cystic Fibrosis, Infectious Diseases, Osteoporosis, Neurology, Pain Management
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
Bayer HealthCare AG Company
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd.
More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"